Ironwood Places $1B Bet on Biotech That Could Bring Its Next Blockbuster GI Drug

By On May 23, 2023

Ironwood Pharmaceuticals is paying $1 billion to acquire VectivBio, a biotech whose lead program could become a blockbuster treatment for a gastrointestinal disorder. Preliminary Phase 3 data are expected by the end of 2023.

Is Generative AI Safe for Healthcare? Yes, With Expert Oversight

He Returned to the US for His Daughter’s Wedding. He Left With a $42,000 Hospital Bill.